Brief: Sienna Biopharmaceuticals Reports Q2 Loss Per Share Of $1.00
Aug 9 (Reuters) - Sienna Biopharmaceuticals Inc SNNA.O :
* SIENNA BIOPHARMACEUTICALS REPORTS SECOND QUARTER 2018
FINANCIAL
RESULTS
* SIENNA BIOPHARMACEUTICALS INC QTRLY LOSS PER SHARE $1.00
* SIENNA BIOPHARMACEUTICALS INC - CASH BURN DURING THREE
MONTHS
ENDED JUNE 30, 2018, WAS APPROXIMATELY $15.8 MILLION
* SIENNA BIOPHARMACEUTICALS INC - SIENNA'S CASH AND CASH
EQUIVALENTS AS OF JUNE 30, 2018, TOTALED APPROXIMATELY $74.9
MILLION
Source text for Eikon: ID:nGNX21kZ3D
Further company coverage: SNNA.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Sienna Biopharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-Adobe, Oracle, Snap, Phreesia, Sarepta, Aquestive Therapeutics, Patterson-UTI
U.S. STOCKS ON THE MOVE-Lululemon, GE, Starbucks, Delta Air Lines, Lumber Liquidators, Lovesac
Sienna Biopharma: Falls on Nasdaq delisting plans
Brief: Sienna Biopharma Says Bankruptcy Court Approved Sale Of Assets Related To SNA-001 For $1.7 Mln In Cash
Brief: Sienna Biopharmaceuticals Announces Court Approval Of Chapter 11 Bidding Procedures